Comparison of intralesional triamcinolone acetonide injection (TA) and curretage on treatment of chalazion

Effect of intralesional triamcinolone acetonide injection (TA) in comparison with incision and curettage (I and C) on treatment of patients with chronic chalazion

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT201606156033N5

Enrollment

Registered

2016-12-21

Start date

2013-07-01

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diseases of the eye and adnexa. Chalazion

Interventions

Intervention 1: Intervention: Triamcinolone Acetate injection into the lesion. Intervention 2: Control: Drainage and curettage of lesion.

Treatment - Surgery

Intervention: Triamcinolone Acetate injection into the lesion

Control: Drainage and curettage of lesion

Eligibility

Sex/Gender

All

Age

13 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: all patients with chronic chalazion which unresponsive to medical treatment. Exclusion criteria: patients with chalazia which have atypical features, concurrent eyelid infection, multiple chalazia on one eyelid, history of previous treatment by TA or I and C

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Decreased size of chalazion. Timepoint: 45 days. Method of measurement: Size of chalazion was measured by ruller and 90% decrease in the size of chalazion was defined as success.	—

Secondary

Measure	Time frame
Recurrence of chalazion. Timepoint: 45 days. Method of measurement: Observation.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactReza Nabie

Nikookari Eye Center

r_nabie@yahoo.com+98 41 3655 1332

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026